Pharmaceutical Business review is using cookies

ContinueLearn More
Close

INC Research

CRO for Drug and Device Development

Logo

INC Research

INC Research is a therapeutically focused global contract research organisation (CRO) with unrivaled expertise and a reputation for conducting global clinical development programs of the highest integrity.

Pharmaceutical and biotechnology companies look to INC Research for a complete range of customised Phase I – Phase IV programs in therapeutic areas of specialty, and in innovative pediatric trials. Our Trusted Process® methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions.

Our mission is to help our customers bring products to market in order to improve world health. We invest in our customers’ success with proven therapeutic foresight and a trusted approach to advance drug and device development.

Phase II-IV operations

The company’s acquisition of the Phase II-IV operations (global clinical development) of MDS Pharma Services in July 2009 substantially deepened its outsourcing power to provide more geographic locations, therapeutic expertise, leadership and process excellence.

INC Research is headquartered in Raleigh, North Carolina, with nearly 2,000 employees and a presence in 40 countries worldwide. Its strong presence in North America; Western, Central and Eastern Europe; and India have been greatly enhanced by MDS GCD’s complementary presence in Western Europe and in the emerging markets of South America, the Asia-Pacific Rim and Africa.

With more global resources, INC Research offers first-hand regional knowledge and experience of cultural nuances and regulatory requirements. Sponsors benefit with an active investigator site database that provides more access to patients that meet specific study protocols.

INC Research HQ

3201 Beechleaf Court
Suite 600
Raleigh, NC 27604-1547
Phone: 919-876-9300
Fax: 919-876-9360

info@incresearch.com
www.incresearch.com

Process-Driven Clinical Research for Drug and Device Development

INC Research has pioneered the concept of process-driven clinical research with its Trusted Process®, which directs sponsors through their drug and device development programs with repeatable and measurable methodology.

Therapeutic Clinical Plan Development

INC Research has built its business and reputation on the strength of its therapeutic expertise. Dedicated clinical operations teams with years of experience provide full clinical plan development that considers the scientific rigour of a specific program. Deploying proven recruitment and retention strategies tailored for each therapeutic area is critical to the success of a trial.

INC Research's longstanding relationships with key thought leaders, investigators (both academic and community based), professional societies, and patient support groups also help meet sponsor trial objectives. For more information, please see our website or contact us.

Custom Phase I-IV Programs for Therapeutics, and Pediatric and Women’s Health Trials

Reinforcing its commitment to its therapeutic focus, INC Research has added respiratory, cardiovascular and endocrinology to its list of therapeutic specialties, which also includes oncology, CNS and infectious diseases.

The combined organisation creates a complete range of customised Phase I-IV programs in these therapeutic areas, and in innovative pediatric and women's health trials. For more information, please see our website or contact us.
Quick Contact INC Research
Quick Contact INC Research
Quick Contact INC Research


Quick Contact INC Research
Quick Contact INC Research
Quick Contact INC Research


Contact INC Research

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact INC Research